About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pancreatic Cancer Clinical Trials in Texas | 655 Studies

Clinical Trials Pancreatic CancerTexas

Pancreatic Cancer Clinical Trials in Texas

Find 655 clinical trials for pancreatic cancer near Texas. Connect with research centers in your area.

All Pancreatic Cancer trials nationwide All trials in Texas

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 181-200 of 655 trials

RecruitingComputed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary CancerThis trial studies how well computed tomography works in diagnosing patients with pancreatic or hepatobiliary cancer.NCT02361320·Houston, Texas Active not recruitingFeasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) InterventionThis is a community-based study requiring participant-self-enrollment, that can help to increase the rates of genetic testing among the family members of people who have been…NCT05677048·Houston, Texas TerminatedTissue Pharmacokinetics of Intraoperative Gemcitabine in Resectable Adenocarcinoma of the PancreasThe goal of this clinical research study is to learn if gemcitabine can enter pancreas cancer cells, to measure the amount of it that may enter the cells, and for biomarker…NCT01276613·Houston, Texas TerminatedPhase 2b Study of GC4711 in Combination With SBRT for Nonmetastatic Pancreatic CancerGTI-4711-201 is designed as a Phase 2b, multicenter, randomized, double-blind, placebo-controlled study to determine the effect to OS by adding GC4711 to SBRT following…NCT04698915·Gilbert, Arizona and 34 others

Pancreatic Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedA Phase II Study of Pioglitazone for Patients With Cancer of the PancreasThis study is being done to determine whether or not addition of the oral medication, pioglitazone to standard chemotherapy, results in improvement of blood tests that measure the…NCT01838317·Dallas, Texas

RecruitingA Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid TumorsThis study will help find the most suitable dose of ASP546C in people with gastric cancer, gastroesophageal junction (GEJ) cancer, pancreatic cancer, and other specific solid…NCT07488676·Birmingham, Alabama and 20 others

Active not recruitingTempus Priority Study: A Pan-tumor Observational StudyObservational study that will be collecting clinical and molecular health information from cancer patients who have received comprehensive genomic profiling and meet the specific…NCT05179824·Dallas, Texas and 1 other

TerminatedA Study to Find a Suitable Dose of ASP4396 in Adults With Solid TumorsGenes contain genetic code which tell the body which proteins to make. Some types of cancer are caused by changes, or mutations, in a gene called KRAS.NCT06364696·Westwood, Kansas and 6 others

CompletedMinocycline Study in Pancreatic Cancer PatientsThe goal of this clinical research study is to learn if minocycline can reduce the side effects of chemotherapy in patients with pancreatic cancer.NCT01693523·Houston, Texas

RecruitingSafety and Efficacy of Endoscopic Ultrasound (EUS) Guided Radiofrequency Ablation (RFA) in the Treatment of Pancreatic LesionsThis is a 7-year prospective single-center registry study to assess the safety and efficacy of Endoscopic Ultrasound (EUS) Guided Radiofrequency Ablation (RFA) in the treatment of…NCT07737171·Houston, Texas

CompletedARQ 501 in Combination With Gemcitabine in Subjects With Pancreatic CancerThe study will document the safety and efficacy of the combination of ARQ 501 and gemcitabine in patients with treatment-naïve, unresectable, metastatic pancreatic adenocarcinoma.NCT00102700·Mobile, Alabama and 14 others

CompletedBevacizumab, Erlotinib and Capecitabine for Advanced Pancreatic CancerThe goal of this clinical research study is to find the highest tolerable dose of capecitabine, erlotinib hydrochloride, and bevacizumab that can be given in combination with…NCT00614653·Houston, Texas

TerminatedAdagrasib in Combination With BI 1701963 in Patients With Cancer (KRYSTAL 14)This study will evaluate safety, tolerability, drug levels, molecular effects and clinical activity of MRTX849 (adagrasib) in combination with BI 1701963 in patients with advanced…NCT04975256·St Louis, Missouri and 3 others

CompletedDolastatin 10 in Treating Patients With Metastatic Pancreatic CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00003677·Chicago, Illinois and 1 other

CompletedA Study of CM24 in Combination with Nivolumab in Adults with Advanced Solid TumorsThis is an open-label, multicenter, multi-dose escalation and dose expansion study in subjects with selected advanced solid tumors (Part A) and advanced metastatic pancreatic…NCT04731467·Scottsdale, Arizona and 17 others

CompletedA Phase 1b/2 Study of OMP-59R5 (Tarextumab) in Combination With Nab-Paclitaxel and Gemcitabine in Subjects With Previously Untreated Stage IV Pancreatic CancerThe study consists of a Phase1b lead-in portion to determine the maximum tolerated dose (MTD) of OMP-59R5 in combination with nab-paclitaxel and gemcitabine followed by a Phase 2…NCT01647828·Goodyear, Arizona and 25 others

Active not recruitingA Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic CancerSubjects will be offered the opportunity to participate in a randomized, controlled, 2-arm, unblinded multicenter trial (RCT).NCT03899636·Miami, Florida and 5 others

TerminatedA Phase I/II Study of Lenalidomide in Combination With Gemcitabine in Patients With Untreated Advanced Carcinoma of the PancreasPhase I will determine the MDT and evaluate the safety profile of oral lenalidomide days 1-21 and weekly gemcitabine days 1, 8, \& 15 in 28 day cycles Phase II will explore the…NCT00179751·Metairie, Louisiana and 5 others

RecruitingA Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic AlterationsThis phase II study evaluates how well pemigatinib works for the treatment of adult patients with pancreatic cancer that has spread from where it first started to nearby tissue…NCT06906562·Birmingham, Alabama and 108 others

TerminatedStudy With Gemcitabine and RTA 402 for Patients With Unresectable Pancreatic CancerThis study assesses the safety and efficacy of RTA 402 in combination with gemcitabine in patients with unresectable pancreatic cancer.NCT00529113·Denver, Colorado and 4 others

PreviousPage 10 of 33Next

Other Conditions in Texas

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia